Spratt D I, Finkelstein J S, Badger T M, Butler J P, Crowley W F
J Clin Endocrinol Metab. 1986 Jul;63(1):143-50. doi: 10.1210/jcem-63-1-143.
Previous investigations of the effects of GnRH on pituitary LH responses in normal men required pharmacological doses of GnRH to avoid the confounding effects of endogenous GnRH secretion and employed nonphysiological dose intervals. To examine the role of GnRH in determining both the qualitative and quantitative nature of physiological LH responses, we studied five GnRH-deficient men in whom pituitary and gonadal function had been normalized with GnRH replacement. Both bio- and immunoactive LH responses were evaluated in these men after a wide range of GnRH doses (7.5-250 ng/kg) administered at a physiological frequency (every 2 h), while gonadal steroid levels were within the normal adult male range. In addition, the amplitude and contour of the immunoactive LH pulses were compared to those of 15 normal men to assure that these experiments achieved physiological pituitary responses. The relationship between bio- and immunoactive LH was compared between patients, between doses as the amount of GnRH was increased, and within pulses of LH. As the dose of GnRH was increased, both bio- and immunoactive LH responses increased in a log-linear fashion when assessed by both amplitude (r = 0.96 for bioactive LH and r = 0.98 for immunoactive LH) and area under the curve (r = 0.99 for bioactive LH and r = 0.97 for immunoactive LH). GnRH doses of 7.5 and 25 ng/kg produced LH responses with amplitudes similar to those in normal men. The relationship between bio- and immunoactive LH between patients and between differing doses of GnRH was analyzed by comparing the slopes of lines fit to individual bioactive vs. immunoactive LH plots after each dose of GnRH in each patient. There was a marked variation in the relationship of bio- to immunoactive LH between patients (P less than 0.005). No change was found in the biopotency of LH as the dose of GnRH was increased (P less than 0.10). Finally, no variation of the bioactivity of LH was evident within individual pulses. We conclude that a log-linear relationship exists between doses of GnRH that produce physiological LH pulses and both bio- and immunoactive LH responses; the bioactivity of secreted LH varies markedly between patients; the relative bioactivity of LH in an individual does not change as the dose of GnRH is increased; and no change in bioactivity of LH responses was demonstrated within pulses of LH.
先前对GnRH对正常男性垂体促黄体生成素(LH)反应影响的研究需要使用药理剂量的GnRH,以避免内源性GnRH分泌的混杂效应,并采用非生理剂量间隔。为了研究GnRH在决定生理性LH反应的定性和定量性质方面的作用,我们研究了五名GnRH缺乏的男性,他们的垂体和性腺功能已通过GnRH替代治疗恢复正常。在以生理频率(每2小时一次)给予广泛范围的GnRH剂量(7.5 - 250 ng/kg)后,评估了这些男性的生物活性和免疫活性LH反应,此时性腺类固醇水平处于正常成年男性范围内。此外,将免疫活性LH脉冲的幅度和轮廓与15名正常男性的进行比较,以确保这些实验实现了生理性垂体反应。比较了患者之间、随着GnRH剂量增加时不同剂量之间以及LH脉冲内生物活性和免疫活性LH之间的关系。随着GnRH剂量的增加,当通过幅度(生物活性LH的r = 0.96,免疫活性LH的r = 0.98)和曲线下面积(生物活性LH的r = 0.99,免疫活性LH的r = 0.97)评估时,生物活性和免疫活性LH反应均呈对数线性增加。7.5和25 ng/kg的GnRH剂量产生的LH反应幅度与正常男性相似。通过比较每个患者每次给予GnRH剂量后,拟合个体生物活性与免疫活性LH图的直线斜率,分析了患者之间以及不同剂量GnRH之间生物活性和免疫活性LH的关系。患者之间生物活性与免疫活性LH的关系存在显著差异(P < 0.005)。随着GnRH剂量的增加,LH的生物效价未发现变化(P < 0.10)。最后,在单个脉冲内未发现LH生物活性的变化。我们得出结论,产生生理性LH脉冲的GnRH剂量与生物活性和免疫活性LH反应之间存在对数线性关系;分泌的LH的生物活性在患者之间有显著差异;个体中LH的相对生物活性不会随着GnRH剂量的增加而改变;并且在LH脉冲内未证明LH反应的生物活性有变化。